Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 26956728)

Published in Mol Cancer on March 08, 2016

Authors

Tianli Fan1, Jing Chen2,3, Lirong Zhang4, Pan Gao5, Yiran Hui6, Peirong Xu7, Xiaqing Zhang8, Hongtao Liu9

Author Affiliations

1: Department of Pharmacology, School of Basic Medicine, Zhengzhou University, Zhengzhou, Henan, 450001, P.R. China. fantianlipp@163.com.
2: Department of Pharmacology, School of Basic Medicine, Zhengzhou University, Zhengzhou, Henan, 450001, P.R. China. chenjing314919@163.com.
3: Department of Oncology, the Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, 450007, P.R. China. chenjing314919@163.com.
4: Department of Pharmacology, School of Basic Medicine, Zhengzhou University, Zhengzhou, Henan, 450001, P.R. China. lrzhang@zzu.edu.cn.
5: Department of Pharmacology, School of Basic Medicine, Zhengzhou University, Zhengzhou, Henan, 450001, P.R. China. 823195194@qq.com.
6: Department of Pharmacology, School of Basic Medicine, Zhengzhou University, Zhengzhou, Henan, 450001, P.R. China. 18737123365@163.com.
7: School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, 450001, P.R. China. xupr717171@sina.com.
8: Laboratory for Cell Biology, College of Life Sciences of Zhengzhou University, Zhengzhou, Henan, 450001, P.R. China. zhangxq2010@126.com.
9: Laboratory for Cell Biology, College of Life Sciences of Zhengzhou University, Zhengzhou, Henan, 450001, P.R. China. liuht1230@126.com.

Articles cited by this

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27

Global cancer statistics. CA Cancer J Clin (2011) 185.92

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16

Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38

Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res (2000) 3.41

Palliation of malignant dysphagia in esophageal cancer: a literature-based review. J Support Oncol (2006) 2.61

Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer (2002) 2.51

Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer (2003) 2.23

Genetic polymorphisms and esophageal cancer risk. Int J Cancer (2007) 2.02

Identification of novel human genes evolutionarily conserved in Caenorhabditis elegans by comparative proteomics. Genome Res (2000) 1.99

A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressors. Cell (2004) 1.73

BCL2 family of apoptosis-related genes: functions and clinical implications in cancer. Crit Rev Clin Lab Sci (2006) 1.59

Mitochondrial dysfunction in cancer. Front Oncol (2013) 1.57

Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis. Mol Biol Cell (2011) 1.54

Crystal structure of a human peptidyl-tRNA hydrolase reveals a new fold and suggests basis for a bifunctional activity. J Biol Chem (2003) 1.44

Targeting the Bcl-2 family for cancer therapy. Expert Opin Ther Targets (2012) 1.33

Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Carcinogenesis (2012) 1.32

A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways. Cancer Res (2011) 1.05

Chemoprevention of esophageal squamous cell carcinoma. Toxicol Appl Pharmacol (2007) 1.04

Bit-1 mediates integrin-dependent cell survival through activation of the NFkappaB pathway. J Biol Chem (2011) 1.03

Recent advances in the regulation of matrix metalloproteinase 2 activation: from basic research to clinical implication (Review). Oncol Rep (2002) 0.99

TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells. Mol Cancer Res (2012) 0.98

Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting. Carcinogenesis (2014) 0.97

Esophageal cancer: current and emerging therapy modalities. Expert Rev Anticancer Ther (2008) 0.96

Metastasis of tumor cells is enhanced by downregulation of Bit1. PLoS One (2011) 0.94

Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway. Mol Cancer (2014) 0.94

Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy. J Pharm Pharmacol (2012) 0.91

Altering FAK-paxillin interactions reduces adhesion, migration and invasion processes. PLoS One (2014) 0.89

Measurement of extent of spread of oesophageal squamous carcinoma by serial sectioning. J Clin Pathol (1996) 0.88

EFEMP1 promotes the migration and invasion of osteosarcoma via MMP-2 with induction by AEG-1 via NF-κB signaling pathway. Oncotarget (2015) 0.88

Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy. Cancer Lett (2006) 0.88

Paxillin controls endothelial cell migration and tumor angiogenesis by altering neuropilin 2 expression. J Cell Sci (2014) 0.87

Dysfunction of Endoplasmic Reticulum (ER) and Mitochondria (MT) in Alzheimer's Disease: The Role of the ER-MT Cross-Talk. Curr Alzheimer Res (2015) 0.87

The anoikis effector Bit1 displays tumor suppressive function in lung cancer cells. PLoS One (2014) 0.86

Oesophageal cancer in The Netherlands: increasing incidence and mortality but improving survival. Eur J Cancer (2007) 0.86

Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer. Dig Dis Sci (2013) 0.83

The roles of Wnt5a, JNK and paxillin in the occurrence of metastasis of pancreatic adenocarcinoma. Int J Clin Oncol (2013) 0.82

Implications of Bit1 and AIF overexpressions in esophageal squamous cell carcinoma. Tumour Biol (2013) 0.82

Expression of Paxillin is Correlated with Clinical Prognosis in Colorectal Cancer Patients. Med Sci Monit (2015) 0.81

Focal-adhesion-independent integrin-αv regulation of FAK and c-Myc is necessary for 3D skin formation and tumor invasion. J Cell Sci (2015) 0.80

Pathological implication and function of Bcl2-inhibitor of transcription in ovarian serous papillary adenocarcinomas. Neoplasma (2013) 0.80

Antroquinonol Targets FAK-Signaling Pathway Suppressed Cell Migration, Invasion, and Tumor Growth of C6 Glioma. PLoS One (2015) 0.79

Mitochondrial dysfunction and Parkinson disease: a Parkin-AMPK alliance in neuroprotection. Ann N Y Acad Sci (2015) 0.79

Anti-metastatic action of FAK inhibitor OXA-11 in combination with VEGFR-2 signaling blockade in pancreatic neuroendocrine tumors. Clin Exp Metastasis (2015) 0.78

Cytoskeletal Focal Adhesion Proteins Fascin-1 and Paxillin Are Predictors of Malignant Progression and Poor Prognosis in Human Breast Cancer. J Environ Pathol Toxicol Oncol (2015) 0.78

Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERK-mediated stabilization of Bcl-2 protein by phosphorylation at Serine 87. Oncotarget (2015) 0.77

Down-regulation of the apoptosis-inducing factor or Bcl-2 inhibitor of transcription by RNA interference can alleviate TAp63gamma-induced apoptosis in esophageal squamous carcinoma EC9706 cells. Int J Oncol (2009) 0.77

Estrogen decreases anoikis of ovarian cancer cell line Caov-3 through reducing release of Bit1. DNA Cell Biol (2014) 0.77

Selenite activates the ATM kinase-dependent DNA repair pathway in human osteosarcoma cells with mitochondrial dysfunction. Biochem Pharmacol (2015) 0.77

Monoclonal antibodies against human bit1, an apoptosis-associated mitochondrial protein. Hybridoma (Larchmt) (2009) 0.76